Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Accenture
Julphar
Cantor Fitzgerald
Moodys
Chinese Patent Office
Daiichi Sankyo
Novartis
QuintilesIMS
Farmers Insurance

Generated: February 23, 2018

DrugPatentWatch Database Preview

ETHRIL 500 Drug Profile

« Back to Dashboard

Which patents cover Ethril 500, and when can generic versions of Ethril 500 launch?

Ethril 500 is a drug marketed by Bristol Myers Squibb and is included in one NDA.

The generic ingredient in ETHRIL 500 is erythromycin stearate. There are one hundred and one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the erythromycin stearate profile page.
Summary for ETHRIL 500
Drug patent expirations by year for ETHRIL 500

US Patents and Regulatory Information for ETHRIL 500

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb ETHRIL 500 erythromycin stearate TABLET;ORAL 061605-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Baxter
Colorcon
AstraZeneca
Moodys
QuintilesIMS
McKinsey
Federal Trade Commission
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot